Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Implantable Pulse Generator Market Expected to Grow Between 2025 And 2029?

The market for implantable pulse generators has experienced swift expansion in recent years. The market is predicted to rise from a size of $133.75 billion in 2024 to $148.38 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.9%. The growth observed in the historic period is grounded in several factors, including an increase in home healthcare facilities, more prevalent use of neuromodulation in managing diseases, higher patient diagnosis rates, increased utilization of medical devices, and heightened patient awareness.

What Growth Rate Is Anticipated for the Implantable Pulse Generator Market in the Coming Years?

The market size for implantable pulse generators is projected to experience swift expansion in the coming years, with a forecasted growth to $222.76 billion in 2029 and a compound annual growth rate (CAGR) of 10.7%. This anticipated growth during the forecast period can be credited to factors such as increased spending on healthcare, preferences of patients for minimally invasive treatments, beneficial reimbursement schemes, the widening of application domains, and the escalating use of implants in various therapies. Key trends to watch for during the forecast period include the shrinking sizes of devices, improvements in battery longevity, the advent of wireless connectivity, advancements in smart implantable devices, and the incorporation of artificial intelligence and machine learning.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18639&type=smp

Who Are the Leading Companies in the Implantable Pulse Generator Market?

Major companies operating in the implantable pulse generator market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Integer Holdings Corporation, Livanova plc, Inspire Medical Systems Inc., Nevro Corp, Impulse Dynamics Ltd., Valtronic Inc., NeuroPace Inc., SPR Therapeutics Inc., Stimwave LLC, SetPoint Medical, ReShape Lifesciences Inc., Synapse Biomedical Inc., Nuvectra Medical Inc., NeuroSigma Inc., Nalu Medical Inc., MainStay Medical International PLC, Dextronix Inc., BioControl Medical Inc.

What Are the Key Drivers of the Implantable Pulse Generator Market?

The implantable pulse generator market is anticipated to thrive in the future due to an increasing prevalence of neurological disorders. When we speak of neurological disorders, we refer to issues concerning the nervous system, brain, and spinal cord, which can hamper functionalities like cognition, sensation, and movement. Growth in neurological disorders can often be linked to elements like aging populations, changed lifestyles, enhanced diagnostic mechanisms, and environmental effects. Implantable pulse generators aid in the treatment of neurological disorders by delivering specific electrical impulses to control abnormal neural activities and reduce symptoms. For example, the Parkinson Foundation, a nonprofit organization based in the US, highlighted in December 2022 that by 2020, the number of Parkinson’s disease (PD) sufferers in the US came close to 930,000 and this figure is expected to touch 1.2 million by 2030. Hence, the escalation in neurological disorders’ incidence is fuelling the expansion of the implantable pulse generator market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=18639&type=smp

What Are the Key Market Segments in the Implantable Pulse Generator Industry?

The implantable pulse generator market covered in this report is segmented –

1) By Product: Implantable Cardiac Pacemakers, Implantable Defibrillators, Cochlear Implants, Implantable Nerve Stimulators (Fes), Implantable Infusion Pumps, Implantable Active Monitoring Devices

2) By Charging Type: Rechargeable, Non Rechargeable

3) By Application: Cardiovascular Diseases, Movement Disorders, Orthopedic Diseases, Other Applications

4) By End User: Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics

Subsegments:

1) By Implantable Cardiac Pacemakers: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers

2) By Implantable Defibrillators: Implantable Cardioverter Defibrillators (ICD), Subcutaneous Implantable Defibrillators (S-ICD)

3) By Cochlear Implants: Single-Channel Cochlear Implants, Multi-Channel Cochlear Implants

4) By Implantable Nerve Stimulators (Fes): Functional Electrical Stimulation (FES) Devices For Motor Function Restoration, Spinal Cord Stimulation Devices

5) By Implantable Infusion Pumps: Insulin Pumps, Pain Management Pumps, Intrathecal Drug Delivery Pumps

6) By Implantable Active Monitoring Devices: Continuous Glucose Monitoring Systems, Cardiac Monitoring Devices, Neurological Monitoring Devices

What Are the Latest Trends in the Implantable Pulse Generator Market?

Prominent businesses in the implantable pulse generator market are prioritizing the creation of advanced neuromodulation devices. They aim to improve treatment effectiveness, lead to better patient outcomes, and broaden the use of these devices across diverse neurological conditions. A neuromodulation device is a medical tool devised to modify nerve activity via the distribution of electrical or pharmaceutical agents straight to targeted sections of the nervous system. To illustrate, in November 2022, CVRx Inc., a medical device firm based in the US, unveiled the latest Barostim NEO2 IPG, an implantable pulse generator designed for patients receiving therapy. The Barostim system utilizes neuromodulation to enhance heart failure symptoms via delivery of electrical pulses to the baroreceptors located in the wall of the carotid artery. This action stimulates the body’s baroreflex, setting off an autonomic response in the heart. The therapeutic goal is to reestablish equilibrium in the autonomic nervous system and mitigate heart failure symptoms.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/implantable-pulse-generator-global-market-report

What Are the Key Regional Markets in the Implantable Pulse Generator Industry?

North America was the largest region in the implantable pulse generator market in 2023. The regions covered in the implantable pulse generator market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18639

This Report Delivers Insight On:

1. How big is the implantable pulse generator market, and how is it changing globally?

2. Who are the major companies in the implantable pulse generator market, and how are they performing?

3. What are the key opportunities and risks in the implantable pulse generator market right now?

4. Which products or customer segments are growing the most in the implantable pulse generator market?

5. What factors are helping or slowing down the growth of the implantable pulse generator market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model